Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernardetta Nardelli

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Leukemia & Lymphoma|October 23, 2002
B lymphocyte stimulator (BLyS): a therapeutic trichotomy for the treatment of B lymphocyte diseasesBernardetta Nardelli, Paul A Moore, Yuling Li, et al.
Infection and Immunity|December 23, 2003
Selective induction of tumor necrosis receptor factor 6/decoy receptor 3 release by bacterial antigens in human monocytes and myeloid dendritic cellsSunghee Kim, William J McAuliffe, Liubov S Zaritskaya, et al.
Nature Immunology|August 3, 2002
DCs induce CD40-independent immunoglobulin class switching through BLyS and APRILMikhail B Litinskiy, Bernardetta Nardelli, David M Hilbert, et al.
The Journal of Experimental Medicine|February 5, 2003
G-CSF-stimulated neutrophils are a prominent source of functional BLySPatrizia Scapini, Bernardetta Nardelli, Gianpaolo Nadali, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|March 18, 2006
Analysis of IFN-kappa expression in pathologic skin conditions: downregulation in psoriasis and atopic dermatitisClaudia Scarponi, Bernardetta Nardelli, David W Lafleur, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2002
Regulatory effect of IFN-kappa, a novel type I IFN, on cytokine production by cells of the innate immune systemBernardetta Nardelli, Liubov Zaritskaya, Mark Semenuk, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 22, 2002
Pharmacokinetic and pharmacodynamic studies of a human serum albumin-interferon-alpha fusion protein in cynomolgus monkeysBlaire L Osborn, Henrik S Olsen, Bernardetta Nardelli, et al.
Endocrinology|September 24, 2005
Osteostat/tumor necrosis factor superfamily 18 inhibits osteoclastogenesis and is selectively expressed by vascular endothelial cellsBernardetta Nardelli, Liubov Zaritskaya, William McAuliffe, et al.
Blood|September 11, 2004
Proinflammatory mediators elicit secretion of the intracellular B-lymphocyte stimulator pool (BLyS) that is stored in activated neutrophils: implications for inflammatory diseasesPatrizia Scapini, Antonio Carletto, Bernardetta Nardelli, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 9, 2002
BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseasesViktor Roschke, Svetlana Sosnovtseva, Christopher D Ward, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Leukemia & Lymphoma|October 23, 2002
B lymphocyte stimulator (BLyS): a therapeutic trichotomy for the treatment of B lymphocyte diseasesBernardetta Nardelli, Paul A Moore, Yuling Li, et al.
Infection and Immunity|December 23, 2003
Selective induction of tumor necrosis receptor factor 6/decoy receptor 3 release by bacterial antigens in human monocytes and myeloid dendritic cellsSunghee Kim, William J McAuliffe, Liubov S Zaritskaya, et al.
Nature Immunology|August 3, 2002
DCs induce CD40-independent immunoglobulin class switching through BLyS and APRILMikhail B Litinskiy, Bernardetta Nardelli, David M Hilbert, et al.
The Journal of Experimental Medicine|February 5, 2003
G-CSF-stimulated neutrophils are a prominent source of functional BLySPatrizia Scapini, Bernardetta Nardelli, Gianpaolo Nadali, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|March 18, 2006
Analysis of IFN-kappa expression in pathologic skin conditions: downregulation in psoriasis and atopic dermatitisClaudia Scarponi, Bernardetta Nardelli, David W Lafleur, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2002
Regulatory effect of IFN-kappa, a novel type I IFN, on cytokine production by cells of the innate immune systemBernardetta Nardelli, Liubov Zaritskaya, Mark Semenuk, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 22, 2002
Pharmacokinetic and pharmacodynamic studies of a human serum albumin-interferon-alpha fusion protein in cynomolgus monkeysBlaire L Osborn, Henrik S Olsen, Bernardetta Nardelli, et al.
Endocrinology|September 24, 2005
Osteostat/tumor necrosis factor superfamily 18 inhibits osteoclastogenesis and is selectively expressed by vascular endothelial cellsBernardetta Nardelli, Liubov Zaritskaya, William McAuliffe, et al.
Blood|September 11, 2004
Proinflammatory mediators elicit secretion of the intracellular B-lymphocyte stimulator pool (BLyS) that is stored in activated neutrophils: implications for inflammatory diseasesPatrizia Scapini, Antonio Carletto, Bernardetta Nardelli, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 9, 2002
BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseasesViktor Roschke, Svetlana Sosnovtseva, Christopher D Ward, et al.
Pageof 2